Flucytosine

Flucytosine

SCHEMBL3870974

Cl.Nc1nc(=O)[nH]cc1F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TMP1

The experimentally established mechanism targets of Flucytosine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
CYP19A1 P11511 1/20 0.35
TSHR P16473 1/20 0.35
THPO P40225 1/20 0.35
MTOR P42345 1/20 0.35
HTT P42858 1/20 0.35
HBB P68871 1/20 0.35
PMP22 Q01453 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CTSK P43235 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Flucytosine SCHEMBL24063 0.98
Flucytosine SCHEMBL8160959 0.98 ALDH1A1 (0.37) ALDH1A1LMNAMAPTCYP19A1TSHR
Flucytosine SCHEMBL28748160 0.96
Flucytosine SCHEMBL29100530 0.96 ALDH1A1 (0.35) ALDH1A1LMNAMAPTCYP19A1TSHR
Flucytosine SCHEMBL3871370 0.96 ALDH1A1 (0.35) ALDH1A1LMNAMAPTCYP19A1TSHR
Flucytosine SCHEMBL3869716 0.96 ALDH1A1 (0.35) ALDH1A1LMNAMAPTCYP19A1TSHR
Flucytosine SCHEMBL3868918 0.96 ALDH1A1 (0.35) ALDH1A1LMNAMAPTCYP19A1TSHR
Flucytosine SCHEMBL1050449 0.94 ALDH1A1 (0.34) ALDH1A1LMNAMAPTCYP19A1TSHR
Flucytosine SCHEMBL3867430 0.92 ALDH1A1 (0.33) ALDH1A1LMNAMAPTCYP19A1TSHR
Flucytosine SCHEMBL27696081 0.92 ALDH1A1 (0.33) ALDH1A1LMNAMAPTCYP19A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090068287-A1 Novel topical formulations of flucytosine and uses thereof CAMARGO PHARMACEUTICAL SERVICES LLC 2009-03-12 US claimed
EP-0413246-A2 Reparation of parenteral forms, their application in a kit and 5-Fluorcytosin-Monochlorhydrate F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1991-02-20 EP claimed
JP-3090019-A None JP disclosed
CN-108586268-A N, the method for accelerine recycling are recycled in a kind of Flucytosine chlorinated effluent 精华制药集团南通有限公司 2018-09-28 CN disclosed
US-20090068287-A1 Novel topical formulations of flucytosine and uses thereof CAMARGO PHARMACEUTICAL SERVICES LLC 2009-03-12 US disclosed
JP-H0390019-A PREPARATION OF PARENTERALLY ADMINISTRABLE SOLUTION OF PHARMACEUTICALLY ACTIVE SUBSTANCE F HOFFMANN LA ROCHE AG 1991-04-16 JP disclosed
EP-0413246-A2 Reparation of parenteral forms, their application in a kit and 5-Fluorcytosin-Monochlorhydrate F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1991-02-20 EP disclosed
EP-0413246-A2 Reparation of parenteral forms, their application in a kit and 5-Fluorcytosin-Monochlorhydrate F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1991-02-20 EP disclosed